Transforming Myelofibrosis: CI Insights into Emerging Therapies and Market Dynamics
In 2025, the global myelofibrosis treatment market was valued at USD 2.6 billion and is anticipated to expand to around USD 3.4 billion by 2033, registering a CAGR of 3.4% over the forecast period. Key drivers behind this market expansion include the growing burden of hematologic malignancies, rising adoption of JAK inhibitors, and the acceleration of pipeline therapies such as nuvisertib,...
0 التعليقات 0 المشاركات 17 مشاهدة 0 معاينة
إعلان مُمول